{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "24208-498",
      "generic_name": "Timolol Maleate",
      "labeler_name": "Bausch & Lomb Incorporated",
      "brand_name": "Timoptic in Ocudose",
      "active_ingredients": [
        {
          "name": "TIMOLOL MALEATE",
          "strength": "3.4 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "24208-498-34",
          "description": "6 POUCH in 1 CARTON (24208-498-34)  / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER",
          "marketing_start_date": "20220217",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Bausch & Lomb Incorporated"
        ],
        "rxcui": [
          "1922876",
          "1922877",
          "1922894",
          "1922895"
        ],
        "spl_set_id": [
          "d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "P8Y54F701R"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "SOLUTION",
      "spl_id": "fb4b627c-422c-471a-bcec-fff7187d79d7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "OPHTHALMIC"
      ],
      "marketing_start_date": "20220217",
      "product_id": "24208-498_fb4b627c-422c-471a-bcec-fff7187d79d7",
      "application_number": "NDA019463",
      "brand_name_base": "Timoptic in Ocudose",
      "pharm_class": [
        "Adrenergic beta-Antagonists [MoA]",
        "beta-Adrenergic Blocker [EPC]"
      ]
    }
  ]
}